Antimicrobial resistance (AMR) is a growing threat to global health. It affects humans, animals, and the environment, making it a complex issue. A team from various leading institutions, including the University of Edinburgh and the London School of Hygiene and Tropical Medicine, has pointed out significant gaps in our understanding of AMR. These gaps hinder the effective translation of scientific findings into meaningful policies.
Understanding AMR
AMR is often referred to as a “wicked problem.” This means it’s complicated and hard to address. Unlike sudden health crises, AMR builds up over time and is not easily visible. It doesn’t come from one single pathogen; rather, it involves many microbes. This complexity makes it difficult to communicate the urgency of the issue.
One major challenge is that the benefits and costs of interventions are often imbalanced. For example, reducing antimicrobial use (AMU) is crucial, but we lack solid baseline data to make accurate assessments. The relationship between AMU and AMR is not well understood, especially across different settings, such as livestock and aquaculture. Interestingly, environmental factors related to AMR are frequently overlooked.
The Gaps in Current Models
An analysis of 273 population-level models shows concerning deficiencies in how we study AMR. Most models focus only on human health, with a tiny fraction considering animals or plants. Additionally, many models lack sensitivity analyses, which assess how different variables impact outcomes.
Current modelling efforts often remain at the lower levels of a hierarchy, primarily theoretical and lacking real-world validation. For instance, models that successfully addressed the COVID-19 pandemic can’t simply be applied to AMR without substantial adjustments, especially because AMR is more complex.
Drawing Lessons from Climate Change
The researchers suggest we treat AMR like environmental pollution, similar to climate change. This shift could help us utilize strategies that worked for climate action, like crafting economic metrics to inform policy decisions. For example, climate science developed methods for evaluating costs that guided meaningful policy across sectors. However, such frameworks are still absent for AMR, creating a significant missed opportunity to tackle this global issue effectively.
Moving Forward
To combat AMR effectively, we need collaboration across disciplines and countries. Data collection must improve, especially in environmental contexts where we currently have very little information. Efforts like the Digital One Health initiatives aim to make surveillance clearer and more efficient.
Furthermore, transparency in scientific research is crucial for building trustworthy models. If data and methods are shared openly, we can better assess the state of AMR and develop stronger policies.
Conclusion
AMR is an “invisible pandemic,” making it hard to rally political support and resources. Right now, integrated modelling approaches are still in their infancy. There are many knowledge gaps that need to be addressed. A strong collaborative effort is essential to management and policy-making to effectively address this pressing global health crisis.
For more insights into antimicrobial resistance, you can refer to sources like the World Health Organization, which provides valuable data and resources on this issue.
